The Principal Technical Advisor (PTA) provides technical leadership and advice for the design and implementation of innovative strategies and programs to strengthen pharmaceutical systems and bring forward pharmacovigilance (PV) and safety monitoring in countries tied to the MSH-led USAID-funded global Medicines, Technology and Pharmaceutical Services (MTaPS) Activity. The PTA supports regulatory system strengthening (RSS) and pharmacovigilance (PV) activities of the country and contributes to the MTaPS PV strategies and work plans. The PTA works with MTaPS Country Program Director, the Ministry of Health, the National Medicines Regulatory Authority (NMRA) and country partners and stakeholders on the development of RSS and PV strategies based on country evidence, MSH standards and best international practices to achieve sustainable results. The PTA provides guidance to technical staff assigned to specific activities to ensure that the work is of the highest quality. The PTA works closely with other Principal Technical Advisors and Portfolio and Health Element Managers to identify opportunities to use new and existing tools, to coordinate technical work, and to ensure that global (core-funded) initiatives are based on and informed by country-level needs and priorities.
Period of assignment: September 2022 – December 2023
Required:
- A minimum of 8 years of relevant experience or equivalent in international and/or NMRA/ or field public health programs and activities, particularly in the implementation of RSS-PV in developing countries.
- Interest in and experience managing and supervising technical staff.
Preferred:
- Significant relevant experience, including demonstrated expertise, in at least three technical areas of RSS-PV, such as regulatory framework and policy environment, governance and organizational systems for pharmaceutical management, pharmacovigilance and safety monitoring, regulatory system strengthening, pharmaceutical services.
- Experience with NMRA, and previous work with international organizations such as the Global Fund (GF), UNITAID, USAID, WHO and World Bank preferred.
MSH is an equal opportunity employer and will not discriminate against any employee or applicant for employment on the basis of race, color, sex, sexual orientation, gender or gender identity, religion, creed, citizenship, national origin, age, veteran status, or disability unrelated to job requirements. MSH will take affirmative action to ensure that qualified applicants are employed and that employees are treated without regard to their race, age, color, religion, sex, sexual orientation, gender identity, national origin, veteran and disability status. In compliance with U.S. Department of Labor Executive Order 11246, Section 503 of the Rehabilitation Act, and Section 4212 of the Vietnam Era Readjustment Assistance Act, MSH has developed and maintains an affirmative action program and plan.
